Welcome to our dedicated page for Selectquote SEC filings (Ticker: SLQT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SelectQuote, Inc. filings document formal disclosures for a public insurance distribution and healthcare services company. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentation exhibits, and segment information for Senior, Healthcare Services, Life, and SelectRx-related activity.
The company’s regulatory filings also cover capital-structure matters, including a senior secured credit facility and revolving credit facility, as well as NYSE continued-listing compliance disclosures. Governance records include annual meeting voting results for director elections, auditor ratification, and advisory executive-compensation matters, while amended event reports document corrections to previously furnished earnings materials.
SelectQuote, Inc. reported results for the quarter ended September 30, 2025. Total revenue was $328.8 million, up from $292.3 million, driven by Pharmacy revenue of $218.5 million versus $152.9 million. Commissions and other services were $110.3 million versus $139.4 million.
Loss from operations widened to $(40.7) million from $(12.0) million as costs rose with volume. Net interest expense improved to $(11.8) million from $(23.0) million. A $15.0 million non‑cash gain from change in fair value of warrants reduced overall loss, resulting in net loss of $(30.5) million, compared with $(44.5) million a year ago. After $17.5 million of accumulated dividends and accretion on Senior Non‑Convertible Preferred Stock, net loss attributable to common shareholders was $(47.9) million (basic and diluted EPS $(0.26)).
Cash, cash equivalents and restricted cash ended at $15.7 million. Operating cash flow was $(21.6) million. Debt totaled $393.1 million, including Term Loans of $310.4 million and a $15.0 million revolving balance; the company was in compliance with covenants. Shares outstanding were 175,946,798 as of September 30, 2025.
SelectQuote, Inc. announced financial results for its first quarter ended September 30, 2025. The company furnished a press release and investor presentation as Exhibits 99.1 and 99.2, which are incorporated by reference.
The materials are furnished under Item 2.02 and are not deemed filed for purposes of Section 18 of the Exchange Act, nor incorporated into other filings unless specifically referenced. The filing also lists Exhibit 104 for the cover page Inline XBRL data.
SelectQuote, Inc. reported strategic growth in its healthcare and pharmacy businesses while managing leverage and shifting its distribution mix. Pharmacy revenue rose materially, increasing by $263.9 million (57%) in fiscal 2025 driven by a 31% increase in SelectRx members. Commission and other services revenue declined $59.1 million (7%), led by lower Senior commissions and a 4% decrease in approved policies. The company processed over 1.05 million assisted disclaimers with voice AI and saved over 4.7 million minutes of agent time through automation. SelectQuote reduced total debt to $385.1 million at June 30, 2025 (from $683.3 million prior year) after securitization and debt repayments, and held $37.1 million of cash and equivalents. The business remains concentrated: carriers owned by UHC, Aetna and Humana accounted for 37%, 15%, and 11% of revenue in 2025. The company emphasizes maximizing lifetime value (LTV) through AI-driven lead scoring, agent routing and post-sale retention efforts.
SelectQuote, Inc. reported strategic growth in its healthcare and pharmacy businesses while managing leverage and shifting its distribution mix. Pharmacy revenue rose materially, increasing by $263.9 million (57%) in fiscal 2025 driven by a 31% increase in SelectRx members. Commission and other services revenue declined $59.1 million (7%), led by lower Senior commissions and a 4% decrease in approved policies. The company processed over 1.05 million assisted disclaimers with voice AI and saved over 4.7 million minutes of agent time through automation. SelectQuote reduced total debt to $385.1 million at June 30, 2025 (from $683.3 million prior year) after securitization and debt repayments, and held $37.1 million of cash and equivalents. The business remains concentrated: carriers owned by UHC, Aetna and Humana accounted for 37%, 15%, and 11% of revenue in 2025. The company emphasizes maximizing lifetime value (LTV) through AI-driven lead scoring, agent routing and post-sale retention efforts.
SelectQuote, Inc. (SLQT) filed an amendment to a prior Form 8-K to furnish a corrected press release reporting its financial results for the fourth quarter ended June 30, 2025. The press release was furnished as Exhibit 99.1 and is posted on the company’s Investor Relations website. The filing clarifies that the press release is being furnished (not "filed") for purposes of the federal securities laws and is incorporated by reference only as specified.
SelectQuote, Inc. (SLQT) filed an amendment to a prior Form 8-K to furnish a corrected press release reporting its financial results for the fourth quarter ended June 30, 2025. The press release was furnished as Exhibit 99.1 and is posted on the company’s Investor Relations website. The filing clarifies that the press release is being furnished (not "filed") for purposes of the federal securities laws and is incorporated by reference only as specified.
SelectQuote, Inc. disclosed that it reported financial results for the fourth quarter and the fiscal year ended June 30, 2025. The filing states that a related press release and an investor presentation are attached as Exhibits 99.1 and 99.2, and that those exhibits are furnished pursuant to Item 2.02 and are incorporated by reference. The company clarifies these exhibits are being furnished, not "filed", for purposes of Section 18 of the Exchange Act and are not automatically incorporated into other Securities Act or Exchange Act filings.
SelectQuote, Inc. disclosed that it reported financial results for the fourth quarter and the fiscal year ended June 30, 2025. The filing states that a related press release and an investor presentation are attached as Exhibits 99.1 and 99.2, and that those exhibits are furnished pursuant to Item 2.02 and are incorporated by reference. The company clarifies these exhibits are being furnished, not "filed", for purposes of Section 18 of the Exchange Act and are not automatically incorporated into other Securities Act or Exchange Act filings.